Michael Haddadin
@joleukemologist
Hem/Onc l Focus:🩸Myeloid Neoplasm Enthusiast🩸- MPN MDS AML & Allo-SCT I Hob: 🎹 🎬 🎥 ⛰I #JUST🇯🇴#KHCC #SUNY #MSKCC #UMass Chief Res & Fellow #ManUtd #EPL
@sanamloghavi @doctorpemm @TapKadia @beatalleukemia @FadiHaddad_MD @lauracmichaelis @mpdrc @GCC_Cortes @PapaemmanuilLab @joleukemologist @LuskinMarlise @LoriMuffly @GruppSteve
🔎 A fully loaded #PPLC2025 session on all things #myelofibrosis & #mpnsm Mahalo for the insight ! & clinical nuggets of Drs. @doctorpemm, @mpdrc, @lauracmichaelis, @myeloidmalig - for walking us through 🔄 evolving strategies in disease modification—from combos ➕ to immune…
💥 Let’s talk B-ALL! 💬🧠 Our expert panel just crushed it discussing some 🔥 topics: #2025PPLC #Leusm #ALLIn 🩸✨💥 👦 Importance of Pediatric-inspired regimens in adults 👶 🚗🎯CAR-T: tackling resistance & redefining its role in the modern playbook 🧠 CNS disease in ALL!…
🌊 Hang ten, heme fam! #2025PPLC -is officially riding the wave! 🏄♂️🏄♀️ Massive mahalo to all our epic speakers, trailblazing sponsors, and the leukemia ohana for making this collab at Honolua Bay 🌺🤙 Huge shout-out to the organizing committee for steering this surfboard. #Lmsm…
#ASCO25 | @DrJulieVose just outlined how and when to use epcoritamab in patients with relapsed or refractory follicular lymphoma. @ASCO #LYMsm #NonHodgkinLymphoma #ImmunoOnc
🔬Precision medicine isn’t about doing more — it’s about doing right! Not every remission is a victory. 🧓🧓 Geriatric assessment helps us hit that mark 🎯 Inspired by @VijayaRBhatt1 at the @BuffettCancer @unmc doi.org/10.1002/ajh.27… #leumsm #gerionc
New research by @VijayaRBhatt1 shows pre-treatment geriatric assessment in older adults with AML is feasible and can identify functional impairments to guide treatment intensity selection. A practical approach to personalized care! #AML #PrecisionMedicine doi.org/10.1002/ajh.27…
Excited to speak and be part of this incredible conference! Grateful to Dr. @binayshah & the organizers @HematologistMD & @crdangelo9 for the invite—what an inspiring mission behind this foundation @binaytara Kicking off with a power-packed malignant heme update and rich…
We’re off to a strong start at @binaytara Nebraska Congress in Omaha! Dr. Chris D’Angelo (UNMC) of @UNMCHemeOnc kicked things off with an engaging opening. Excellent talk by @joleukemologist! Great energy as experts dive into advances in blood cancer care. #Binaytara #Hematology…
2024 Hematology Highlights: A Post-ASH Review in Omaha. @UNMCHemeOnc unmc.edu/cce/clinicmed/…
Congratulations!
🏆Very grateful to #NIH @theNCI for the #R01 award that will examine #cognition #frailty #ERP/EEG brain activity in older adults with #AML. The R01 was converted to #R37/MERIT award based on its merit. 1/n
Great Work by Dr. @Dr_AmerZeidan & The myeloid Consortium. It is truly an urging need now, for such a change. Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes ashpublications.org/blood/article-… #mdssm #mds2023